SGLT2 inhibitors do not increase risk of fracture compared with other diabetic medications - Healio

5/31/2022 12:00:00 AM2 years 11 months ago
Starting SGLT2 inhibitors among older patients did not increase risk for skeletal fractures compared with the use of dipeptidyl peptidase inhibitors, according to this study.Further, investigators found skeletal fractures were not associated with the eGFR cat…
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio Starting SGLT2 inhibitors among older pa… [+3038 chars]
full article...